ARCHIVES

Clinical Trial System Inefficient, UPCI Director Tells Senate

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995

AMC Cancer Center, Rose Cancer Program Name Douglass Tormey Director; ECG Plans Move To Denver

September 4, 1992

Report to the Nation: Death Rates Continue To Decline Across All Major Disease Sites

January 3, 2014

ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer

September 30, 2005

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978